[{"NetIncomeLoss_1_Q2_USD":-6120741.0,"Assets_0_Q2_USD":230754006.0,"CommonStockSharesIssued_0_Q2_shares":23000000.0,"UnrecognizedTaxBenefits_0_Q2_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":200529440.0,"AssetsCurrent_0_Q2_USD":747181.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":300000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":1520000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2533427.0,"GeneralAndAdministrativeExpense_2_Q2_USD":2668889.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"Liabilities_0_Q2_USD":25224557.0,"Cash_0_Q2_USD":620731.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":600000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":961659.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":3491670.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-2385000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q2_shares":5750000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AssetsHeldInTrustNoncurrent_0_Q2_USD":230006825.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q2_shares":20052944.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1470000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PrepaidExpenseCurrent_0_Q2_USD":126450.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"OperatingIncomeLoss_1_Q2_USD":-2635790.0,"NetIncomeLoss_2_Q2_USD":-435441.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"AdditionalPaidInCapital_0_Q2_USD":13776784.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q2_USD":52500.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_2_Q2_USD":105000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":620731.0,"AccountsPayableCurrent_0_Q2_USD":961659.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-296256.0,"LiabilitiesCurrent_0_Q2_USD":2518387.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-596256.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-6120741.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-435441.0,"CommonStockSharesOutstanding_0_Q2_shares":23000000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-8777645.0,"StockholdersEquity_0_Q2_USD":5000009.0,"ProfitLoss_2_Q2_USD":-435441.0,"CashFDICInsuredAmount_0_Q2_USD":250000.0,"SharePrice_0_Q2_USD":10.0,"PreferredStockSharesAuthorized_0_Q2_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":230754006.0,"PreferredStockValue_0_Q2_USD":null,"InvestmentIncomeInterest_1_Q2_USD":6719.0,"InvestmentIncomeInterest_2_Q2_USD":52676.0,"OperatingIncomeLoss_2_Q2_USD":-2873117.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":-26024.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]